genomics
Cofactor Quickly Moving Immunotherapy Predictive Test to Market With Data From Intermountain Spinout
Premium
Culmination Bio's 4.5 million biospecimens and longitudinal omics and clinical data may help Cofactor rapidly advance the OncoPrism assay into multiple cancer types.
The firm reported Thursday its Q1 revenues declined 30 percent as COVID-19 revenues dwindled but non-COVID organic revenues grew 6 percent.
Agilent Technologies Fiscal Q1 Revenues Rise 5 Percent
The firm's Diagnostics and Genomics Group revenues were up 1 percent with growth in its immunohistochemistry and nucleic acid solutions businesses.
The Canadian company plans to test the clinical utility of its targeted 90-marker panel in monitoring patient response to therapy.
ProPhase Labs Subsidiary, G42 Healthcare Enter Strategic Collaboration for Genomics
The companies plan to explore opportunities in genome sequencing, artificial intelligence, and genomic data sharing, among other areas.
May 4, 2022
Bio-Techne Fiscal Q3 Revenues Rise 19 Percent
Feb 1, 2022
Bio-Techne Fiscal Q2 Revenues Rise 20 Percent
Nov 22, 2021
Agilent Q4 Revenues Rise 12 Percent
Nov 2, 2021
Bio-Techne Fiscal Q1 Revenues Rise 26 Percent
Aug 17, 2021